Your browser doesn't support javascript.
loading
Dyslipidemia and Diabetic Macular Edema: A Systematic Review and Meta-Analysis.
Das, Radha; Kerr, Rebecca; Chakravarthy, Usha; Hogg, Ruth E.
Afiliação
  • Das R; Center for Experimental Medicine, Institute of Clinical Science, Queen's University Belfast, Belfast, Ireland.
  • Kerr R; Center for Experimental Medicine, Institute of Clinical Science, Queen's University Belfast, Belfast, Ireland.
  • Chakravarthy U; Center for Experimental Medicine, Institute of Clinical Science, Queen's University Belfast, Belfast, Ireland.
  • Hogg RE; Center for Experimental Medicine, Institute of Clinical Science, Queen's University Belfast, Belfast, Ireland. Electronic address: r.e.hogg@qub.ac.uk.
Ophthalmology ; 122(9): 1820-7, 2015 Sep.
Article em En | MEDLINE | ID: mdl-26150053
ABSTRACT
TOPIC A systematic review and meta-analysis of dyslipidemia and diabetic macular edema (DME). CLINICAL RELEVANCE Diabetic macular edema causes impairment of vision in patients with diabetes, and dyslipidemia has been reported as a risk factor for its development. A systematic review with a meta-analysis was undertaken to examine the evidence of an association between dyslipidemia and DME.

METHODS:

We defined eligibility criteria as randomized controlled trials (RCTs) and cohort, case-control, and cross-sectional studies reporting on the relationship between blood lipid levels and DME. We performed a literature search in MEDLINE, PubMed, and Embase from inception to September 2014. We used the Newcastle-Ottawa scale to assess the quality of case-control, cross-sectional, and cohort studies, and the Cochrane risk of bias tool for RCTs.

RESULTS:

The search strategy identified 4959 publications. After screening, we selected 21 articles for review (5 cross-sectional, 5 cohort, 7 case-control, and 4 RCTs). Meta-analysis of case-control studies revealed that mean levels of total serum cholesterol (TC), low-density lipoproteins (LDLs), and serum triglycerides (TGs) were significantly higher in patients with DME compared with those without DME (TC 30.08; 95% confidence interval [CI], 21.14-39.02; P < 0.001; LDL 18.62; 95% CI, 5.80-31.43; P < 0.05; TG 24.82; 95% CI, 9.21-40.42; P < 0.05). Meta-analysis of RCTs did not show significant risk in worsening of hard exudates and severity of DME in the lipid-lowering group compared with placebo (hard exudates relative risk, 1.00; 95% CI, 0.47-2.11; P = 1.00; DME relative risk, 1.18; 95% CI, 0.75-1.86; P = 0.48).

CONCLUSIONS:

Despite evidence from the cohort studies and meta-analysis of the case-control studies suggesting a strong relationship between lipid levels and DME, this was not confirmed by the meta-analysis that included only prospective RCTs. Therefore, given the significant public health relevance of the topic, the relationship between lipid levels and DME deserves further investigation.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Edema Macular / Retinopatia Diabética / Dislipidemias Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Edema Macular / Retinopatia Diabética / Dislipidemias Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article